jcisar Profile Banner
justin cisar Profile
justin cisar

@jcisar

Followers
128
Following
1K
Media
12
Statuses
548

father, PhD scientist. #scienceworkssometimes

East Coast, USA
Joined June 2011
Don't wanna be here? Send us removal request.
@tbepler1
tbepler
10 months
Huge thanks to our incredible team @openprotein, especially @timt1630. This is just the beginning of AI systems that truly understand protein biology. I can’t wait to see what the community can do with these models. 13/13
2
1
8
@jcisar
justin cisar
1 year
This work gives us confidence in combining ADME models to calculate early human dose predictions and is being utilized in J&J discovery projects to help advance projects and facilitate decision-making.
0
0
0
@jcisar
justin cisar
1 year
Using a clever approach, Dries and the team demonstrated that the models we evaluated and propagated error allowed for ranking of compounds with 10-fold resolution. In the early drug discovery stage, this is very useful!
1
0
0
@jcisar
justin cisar
1 year
Thus, we focus on a method called 'early human dose prediction,' which uses ADME machine learning model parameters as input. This work addresses a key problem: If each ADME model has error, how does that impact the confidence around early human dose prediction?
1
0
0
@jcisar
justin cisar
1 year
Individual models for preclinical ADME parameters such as clearance, volume of distribution, and oral bioavailability are valuable, but what really matters is the overall effect in vivo and how it could translate to humans.
1
0
0
@jcisar
justin cisar
1 year
I am happy to share our efforts in validating an early human dose prediction method that can be used at the point of design.
pubs.acs.org
Human dose prediction (HDP) is a useful tool for compound optimization in preclinical drug discovery. We describe here our exclusively in silico HDP strategy to triage compound designs for synthesis...
1
1
1
@jcisar
justin cisar
1 year
I am happy to share our efforts in validating an early human dose prediction method that can be used at the point of design.
pubs.acs.org
Human dose prediction (HDP) is a useful tool for compound optimization in preclinical drug discovery. We describe here our exclusively in silico HDP strategy to triage compound designs for synthesis...
1
1
1
@d_vanrompaey
Dries Van Rompaey
1 year
Can we already start thinking about dose at the point of design? We discuss how we try to tackle this challenge and take a closer look at the impact of the accuracy of individual predictions. https://t.co/CH7f2XuQI8
Tweet card summary image
pubs.acs.org
Human dose prediction (HDP) is a useful tool for compound optimization in preclinical drug discovery. We describe here our exclusively in silico HDP strategy to triage compound designs for synthesis...
1
1
4
@d_vanrompaey
Dries Van Rompaey
1 year
I’m truly grateful for the opportunity to work on a challenging problem with this all-star cast of (current and former) JNJ colleagues - at least a few of which I know to be on twitter @jcisar @jedward3!
0
1
2
@jcisar
justin cisar
2 years
Great event!
@ckellzchem
Christopher Kelly
2 years
Last week, myself and Riley Svec (Global Discovery Chemistry at JnJ) had the absolute privilege to co-chair the 2024 JnJ Graduate Research Symposium and host 11 fantastic young chemists at our Spring House, PA Campus. All the students gave phenomenal talks and @KozlowskiMarisa
0
0
5
@ckellzchem
Christopher Kelly
2 years
Last week, myself and Riley Svec (Global Discovery Chemistry at JnJ) had the absolute privilege to co-chair the 2024 JnJ Graduate Research Symposium and host 11 fantastic young chemists at our Spring House, PA Campus. All the students gave phenomenal talks and @KozlowskiMarisa
0
4
27
@Raph_B_NYC
Raphaëlle B.
2 years
📢 one-day free Symposium on Therapeutic Peptides at J&JIM campus in Beerse 🇧🇪. From peptide synthesis to new advances in oral delivery & cell permeability, we will discuss success stories and future perspectives with leaders from academia and industry 👉  https://t.co/doNXShO9Rr
1
6
11
@hardsphere
Huafeng Xu
2 years
I am more worried about AS (artificial stupidity) than AI: there is plenty of dumb things that we have said or written that the large language models may be training on.
0
1
1
@MacMillan_Lab
MacMillan Group
2 years
Check out our recent paper where we take diols and bromoalcohols to form strained bicyclic, fused, and spirocyclic compounds through a new concept, couple-close. Big thanks to our collaborators at Janssen Pharmaceuticals at Spring House! https://t.co/qdKaGWvv5L
1
27
257
@ckellzchem
Christopher Kelly
2 years
Super excited to have our invited review online at @ChemCatChem ! Was a fun collab with @molandergroup André Charette, Todd Marder, Léa Thai-Savard and Jiefeng Hu reviewing some recent cyclopropanation chemistry (my favorite motif!) Check it out! https://t.co/F0A83Wn1Uz
4
1
61
@ckellzchem
Christopher Kelly
2 years
Today is paper day! THRILLED to share the 1st paper from our PCI collab with @MacMillan_Lab on radical annulation chemistry in @Nature . Was fantastic getting to work with Alice & Christian, two amazingly talented young chemists as well as partnering w/ Callie Bryan in
1
6
139
@ACSBioMed
ACS Publications Bio & Med Chem Content
2 years
Christopher T. Walsh: A Prolific Scientist, Effective Academic Leader, and Responsive Mentor Check out the recent In Focus article from #ACSChemBiol associate editor Hening Lin diving deep on Walsh's life and work ➡ https://t.co/5yAphyV1pu
0
3
5
@ChEMBL
ChEMBL Database
2 years
1
7
11
@NikkiG_Conshy
Nikki G
2 years
I'm humbled and grateful to step into this role starting next year. I'm speechless to know that @AcsMedi knows my X/Twitter name 🤩.
@AcsMedi
ACS Division of Medicinal Chemistry
2 years
We are thrilled to introduce the newly elected MEDI Executive Committee members! @NikkiG_Conshy will Chair the Long Range Planning Committee in 2024 and is the Vice-Chair Elect. @conway_group will take on the role of division Treasurer.
2
1
46